Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to $1.7 billion.

  • Fresenius Medical Care AG's Cash & Current Investments rose 12.01% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 12.01%. This contributed to the annual value of $1.7 billion for FY2024, which is 4.31% down from last year.
  • Per Fresenius Medical Care AG's latest filing, its Cash & Current Investments stood at $1.7 billion for FY2024, which was down 4.31% from $1.8 billion recorded in FY2023.
  • Fresenius Medical Care AG's 5-year Cash & Current Investments high stood at $1.8 billion for FY2023, and its period low was $1.2 billion during FY2020.
  • Its 3-year average for Cash & Current Investments is $1.7 billion, with a median of $1.7 billion in 2024.
  • Per our database at Business Quant, Fresenius Medical Care AG's Cash & Current Investments skyrocketed by 41.47% in 2021 and then fell by 8.74% in 2022.
  • MRY analysis of 5 years shows Fresenius Medical Care AG's Cash & Current Investments stood at $1.2 billion in 2020, then skyrocketed by 41.47% to $1.8 billion in 2021, then dropped by 8.74% to $1.6 billion in 2022, then rose by 12.73% to $1.8 billion in 2023, then decreased by 4.31% to $1.7 billion in 2024.
  • Its Cash & Current Investments was $1.7 billion in FY2024, compared to $1.8 billion in FY2023 and $1.6 billion in FY2022.